Skip to Content
New To Chronic Myeloid Leukemia? Get Information Today >>

Medications for Chronic Myelogenous Leukemia

Drugs associated with Chronic Myelogenous Leukemia

The following drugs and medications are in some way related to, or used in the treatment of this condition.

What is Chronic Myelogenous Leukemia: Chronic Myelogenous Leukemia is cancer that starts inside bone marrow. Chronic Myelogenous Leukemia causes an uncontrolled growth of immature cells that make a certain type of white blood cell called myeloid cells. The diseased cells build up in the bone marrow and blood.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
Gleevec Rx D N 21 reviews
9.0

Generic name: imatinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Tasigna Rx D N 17 reviews
8.0

Generic name: nilotinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Sprycel Rx D N 8 reviews
8.0

Generic name: dasatinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Hydrea Rx D N Add review
8.0

Generic name: hydroxyurea systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Cytoxan Rx D N 1 review
10

Generic name: cyclophosphamide systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
imatinib Rx D N 24 reviews
9.0

Generic name: imatinib systemic

Brand name:  Gleevec

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
hydroxyurea Rx D N Add review
8.0

Generic name: hydroxyurea systemic

Brand names:  Hydrea, Droxia

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
nilotinib Rx D N 22 reviews
8.0

Generic name: nilotinib systemic

Brand name:  Tasigna

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Bosulif Rx D N Add review Add

Generic name: bosutinib systemic

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Droxia Rx D N Add review Add

Generic name: hydroxyurea systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Iclusig Rx D N 1 review
5.0

Generic name: ponatinib systemic

Drug class: multikinase inhibitors, BCR-ABL tyrosine kinase inhibitors, VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
anagrelide Off Label Rx C N Add review Add

Generic name: anagrelide systemic

Brand name:  Agrylin

Drug class: miscellaneous uncategorized agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
cyclophosphamide Rx D N 1 review
10

Generic name: cyclophosphamide systemic

Brand names:  Cytoxan, Cytoxan Lyophilized, Neosar

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Cytoxan Lyophilized Rx D N Add review Add

Generic name: cyclophosphamide systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

 
dasatinib Rx D N 9 reviews
8.0

Generic name: dasatinib systemic

Brand name:  Sprycel

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Neosar Rx D N Add review Add

Generic name: cyclophosphamide systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

 
Agrylin Off Label Rx C N Add review Add

Generic name: anagrelide systemic

Drug class: miscellaneous uncategorized agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
Myleran Rx D N 1 review
10

Generic name: busulfan systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Synribo Rx D N Add review Add

Generic name: omacetaxine systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
busulfan Rx D N 1 review
10

Generic name: busulfan systemic

Brand names:  Myleran, Busulfex

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Busulfex Rx D N Add review Add

Generic name: busulfan systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Cytosar-U Rx D N Add review Add

Generic name: cytarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

 
PegIntron Rx C N Add review Add

Generic name: peginterferon alfa-2b systemic

Drug class: antineoplastic interferons, antiviral interferons

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Tarabine PFS Rx D N Add review Add

Generic name: cytarabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

 
bosutinib Rx D N Add review Add

Generic name: bosutinib systemic

Brand name:  Bosulif

Drug class: BCR-ABL tyrosine kinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Page 1 2 Next

Learn more about Chronic Myelogenous Leukemia

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N The drug is not subject to the Controlled Substances Act.
1 The drug has a high potential for abuse. The drug has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug under medical supervision.
2 The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
3 The drug has a potential for abuse less than the drugs in schedules 1 and 2. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.
4 The drug has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
5 The drug has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
Alcohol
X Interacts with Alcohol.

Synonym(s): Cancer, Chronic Myelogenous Leukemia; Chronic Granulocytic Leukemia; CML; Leukemia, Chronic Granulocytic

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide